Evolent Health (NYSE: EVH) reported Q4 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $468.72 million versus the consensus estimate of $469.09 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.